ribavirin has been researched along with Day Blindness in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Alonso, R; González-Diéguez, ML; Junceda-Moreno, J; Pérez-Carro, G; Rodríguez-García, M | 1 |
| Chrissafidou, A; Musch, E | 1 |
| Goldenberg, D; Kurtz, S; Moisseiev, E | 1 |
| King, J; Kooragayala, LM; Liang, C; Schulman, JA | 1 |
| Campbell, C; Farel, C; Koratich, C; Kottilil, S; Masur, H; McLaughlin, M; Metcalf, JA; Polis, MA; Robinson, MR; Suzman, DL | 1 |
| Chisholm, JA; Gavin, M; Keating, D; Mills, PR; Parks, S; Spence, E; Williams, G | 1 |
6 other study(ies) available for ribavirin and Day Blindness
| Article | Year |
|---|---|
[Interferon-alpha toxicity and reversible bilateral optical neuropathy: a timely withdrawal of the drug].
Topics: Adult; Evoked Potentials, Visual; Factor VII Deficiency; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Optic Neuritis; Polyethylene Glycols; Postoperative Complications; Reaction Time; Recombinant Proteins; Ribavirin; Vision Disorders | 2014 |
[Peripheral polyneuropathy and bilateral optic neuropathy during treatment of chronic hepatitis C].
Topics: Adrenal Cortex Hormones; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Optic Nerve Diseases; Papilledema; Peripheral Nervous System Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Vision Disorders | 2009 |
Retinopathy associated with pegylated interferon and ribavirin causing permanent visual impairment in a patient with chronic hepatitis C.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Male; Retinal Diseases; Ribavirin; Vision Disorders; Visual Acuity | 2011 |
Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prospective Studies; Recombinant Proteins; Retina; Retinal Diseases; Ribavirin; Vision Disorders; Visual Fields | 2003 |
Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-2b and ribavirin.
Topics: Adult; Cataract; Color Vision Defects; Eye Diseases; Hepatitis C, Chronic; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Vision Disorders | 2004 |
Retinal toxicity during pegylated alpha-interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation.
Topics: Adult; Antiviral Agents; Delayed-Action Preparations; Electroretinography; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Ischemia; Male; Middle Aged; Photic Stimulation; Polyethylene Glycols; Reaction Time; Recombinant Proteins; Retinal Hemorrhage; Retinal Vessels; Retrospective Studies; Ribavirin; Vision Disorders; Visual Fields | 2005 |